MERCK & CO, INC. for MERCK & CO INC
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (H.R. 452, H.R. 5, S. 668)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER HAWKS BLAND | — |
| ELI JOSEPH | — |
| ROBERT MCMAHON | — |
| JEROME MURRAY | — |
| ERIN POLAK | — |
| ANGELA M STEWART | — |
| JASON BENJAMIN VAN PELT | — |
Medical/Disease Research/Clinical Labs MED
Great Apes (S. 810)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER HAWKS BLAND | — |
| ELI JOSEPH | — |
| JASON BENJAMIN VAN PELT | — |
Trade (domestic/foreign) TRD
Trans-Pacific Partnership (no specific bill); biologic data exclusivity (no specific bill); permanent normal trade relations with Russia (no specific bill); non-tariff trade barriers on U.S. beef (no specific bill)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELI JOSEPH | — |
| ROBERT MCMAHON | — |
| ERIN POLAK | — |
| ANGELA M STEWART | — |
| JASON BENJAMIN VAN PELT | — |
Budget/Appropriations BUD
Deficit reduction (no specific bill); ADAP funding (no specific bill)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER HAWKS BLAND | — |
| ELI JOSEPH | — |
| ROBERT MCMAHON | — |
| JEROME MURRAY | — |
| ERIN POLAK | — |
| ANGELA M STEWART | — |
| JASON BENJAMIN VAN PELT | — |
Consumer Issues/Safety/Products CSP
Access to over-the-counter medications (no specific bill)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER HAWKS BLAND | — |
Manufacturing MAN
Supply chain safety (H.R. 5651; S. 3187); pharmaceutical shortages (H.R. 2245; S. 296;H.R. 5651; S. 3187; H.R. 3381)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER HAWKS BLAND | — |
| ELI JOSEPH | — |
| ROBERT MCMAHON | — |
| JEROME MURRAY | — |
| ERIN POLAK | — |
| ANGELA M STEWART | — |
| JASON BENJAMIN VAN PELT | — |
Taxation/Internal Revenue Code TAX
Comprehensive tax reform (no specific bill); transfer pricing of intangibles (no specific bill); territorial tax system (no specific bill); deferral of taxation of foreign earned income (no specific bill); tax base erosion (no specific bill).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER HAWKS BLAND | — |
| ELI JOSEPH | — |
| ROBERT MCMAHON | — |
| JEROME MURRAY | — |
| ERIN POLAK | — |
| ANGELA M STEWART | — |
| JASON BENJAMIN VAN PELT | — |
Health Issues HCR
Reauthorization of the Prescription Drug User Fee Act (H.R. 5651; S. 3187); incentives for antibiotic research and development (H.R. 2182; H.R. 5651; S. 3187); hepatitis C education (H.R. 3381); improvements to vaccine immunization (no specific bill); 340b (no specific bill).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER HAWKS BLAND | — |
| ELI JOSEPH | — |
| ROBERT MCMAHON | — |
| JEROME MURRAY | — |
| ERIN POLAK | — |
| ANGELA M STEWART | — |
| JASON BENJAMIN VAN PELT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.